SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-020579
Filing Date
2016-11-02
Accepted
2016-11-01 18:21:52
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20160930-10q.htm 10-Q 883712
2 EXHIBIT 31.1 ex-311x20160930.htm EX-31.1 12062
3 EXHIBIT 31.2 ex-312x20160930.htm EX-31.2 12057
4 EXHIBIT 32.1 ex-321x20160930.htm EX-32.1 11336
  Complete submission text file 0001628280-16-020579.txt   4041970

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgls-20160930.xml EX-101.INS 776622
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20160930.xsd EX-101.SCH 30278
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20160930_cal.xml EX-101.CAL 52674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20160930_def.xml EX-101.DEF 134212
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20160930_lab.xml EX-101.LAB 410449
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20160930_pre.xml EX-101.PRE 232047
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 161965887
SIC: 2834 Pharmaceutical Preparations